Johnson & Johnson - Accumulated Depreciation
Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Accumulated-Depreciation" stands at 31.94 Billion United States Dollars as of 06/30/2026, the highest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.63 percent compared to the value the year prior.
The 1 year change in percent is 4.63.
The 3 year change in percent is 4.22.
The 5 year change in percent is 11.79.
The 10 year change in percent is 46.45.
The Serie's change in percent from it's minimum value, on 12/31/2019, to it's latest available value, on 06/30/2026, is +3,237.10%.
The Serie's change in percent from it's maximum value, on 06/30/2026, to it's latest available value, on 06/30/2026, is 0.0%.
Accumulated Depreciation for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Accumulated Depreciation | 905,699,262,464.00 |
 | AbbVie Inc - Accumulated Depreciation | 399,570,305,024.00 |
 | Roche Holding AG - Accumulated Depreciation | 317,433,206,677.55 |
 | AstraZeneca PLC - Accumulated Depreciation | 280,205,508,085.11 |
 | Novartis AG - Accumulated Depreciation | 255,096,620,580.91 |